Intestinal Gastrin/CCKBR (Cholecystokinin B Receptor) Ameliorates Salt-Sensitive Hypertension by Inhibiting Intestinal Na+/H+ Exchanger 3 Activity Through a PKC (Protein Kinase C)-Mediated NHERF1 and NHERF2 Pathway
Xiaoliang JiangYunpeng LiuXin-Yang ZhangXue LiuXing LiuXianxian WuPedro A. JoseShun DuanFu-Jian XuZhiwei YangNHC Key Laboratory of Human Disease Comparative Medicine (The Institute of Laboratory Animal Sciences,CAMS&PUMC),National Human Diseases Animal Model Resource Center,Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases,P.R. China (X.J.,Y.L.,Xue Liu,Xing Liu,X.W.,Z.Y.).Key Lab of Biomedical Materials of Natural Macromolecules (Beijing University of Chemical Technology),Ministry of Education,Beijing Laboratory of Biomedical Materials,Beijing Advanced Innovation Center for Soft Matter Science and Engineering,Beijing University of Chemical Technology,P.R. China (X.-Y.Z.,S.D.,F.-J.X.).Department of Pharmacology and Physiology,The George Washington University School of Medicine and Health Sciences,Washington,DC. (P.A.J.)Division of Kidney Diseases and Hypertension,Department of Medicine,The George Washington University School of Medicine and Health Sciences,Washington,DC. (P.A.J.)
DOI: https://doi.org/10.1161/HYPERTENSIONAHA.121.18791
IF: 9.8968
2022-06-10
Hypertension
Abstract:The present study directly tested the crucial role of intestinal gastrin/CCKBR (cholecystokinin B receptor) in the treatment of salt-sensitive hypertension. Adult intestine-specific Cckbr -knockout mice ( Cckbr fl/fl villin-Cre ) and Dahl salt-sensitive rats were studied on the effect of high salt intake (8% NaCl, 6–7 weeks) on intestinal Na +/ H + exchanger 3 expression, urine sodium concentration, and blood pressure. High-salt diet increased urine sodium concentration and systolic blood pressure to a greater extent in Cckbr fl/fl villin-Cre mice and Dahl salt-sensitive rats than their respective controls, Cckbr fl/fl villin mice and SS13 BN rats. We constructed gastrin-SiO 2 microspheres to enable gastrin to stimulate specifically and selectively intestinal CCKBR without its absorption into the circulation. Gastrin-SiO 2 microspheres treatment prevented the high salt-induced hypertension and increase in urine Na concentration by inhibiting intestinal Na +/ H + exchanger 3 trafficking and activity, increasing stool sodium without inducing diarrhea. Gastrin-mediated inhibition of intestinal Na +/ H + exchanger 3 activity, related to a PKC (protein kinase C)-mediated activation of NHERF1 and NHERF2. These results support a crucial role of intestinal gastrin/CCKBR in decreasing intestinal sodium absorption and keeping the blood pressure in the normal range. The gastrointestinal administration of gastrin-SiO 2 microspheres is a promising and safe strategy to treat salt-sensitive hypertension without side effects.
peripheral vascular disease